Sector News

Latest News: Life sciences

February 28, 2021
Life sciences

The deal will see Microsoft use its capabilities in computational services, cloud computing and artificial intelligence to support drug discovery and development at UCB.

February 28, 2021
Life sciences

The planned closures come as GSK has agreed to sell its cephalosporins antibiotics business to Sandoz, a division of Swiss pharma firm Novartis, for as much as US$500m.

February 28, 2021
Life sciences

“The launch of these new formulations provides the nutritional market with much-needed alternative coating systems that address clean label consumer preferences and are easy to implement,” says Kelly Boyer, vice president film coatings at Colorcon.

February 28, 2021
Life sciences

The collaboration that harnesses the companies’ collective expertise is a “critical step forward” in addressing women’s health through the microbiome, according to Ken Blount, chief scientific officer at Rebiotix and vice president of microbiome research at Ferring Pharmaceuticals.

February 21, 2021
Life sciences

Novadiscovery uses its so-called JINKO platform that runs disease models on virtual patients to support decision-making and de-risk clinical development.

Subscribe to our Weekly Newsletter

We're easy to reach